Aiping D. Li
101 Longmian Avenue
Nanjing, 211166, China
Nanjing, 211166, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
JAC4 Alleviates Rotenone-Induced Parkinson's Disease through the Inactivation of the NLRP3 Signal Pathway.
Journal: Antioxidants (Basel, Switzerland)
Published: March 19, 2023
JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis.
Journal: International journal of molecular sciences
Published: February 04, 2023
JWA inhibits nicotine-induced lung cancer stemness and progression through CHRNA5/AKT-mediated JWA/SP1/CD44 axis.
Journal: Ecotoxicology and environmental safety
Published: January 18, 2023
Targeting JWA for Cancer Therapy: Functions, Mechanisms and Drug Discovery.
Journal: Cancers
Published: August 31, 2022
JAC4 Protects from X-ray Radiation-Induced Intestinal Injury by JWA-Mediated Anti-Oxidation/Inflammation Signaling.
Journal: Antioxidants (Basel, Switzerland)
Published: May 02, 2022
Jwa participates the maintenance of intestinal epithelial homeostasis via ERK/FBXW7-mediated NOTCH1/PPARγ/STAT5 axis and acts as a novel putative aging related gene.
Journal: International journal of biological sciences
Published: March 09, 2022
JAC1 targets YY1 mediated JWA/p38 MAPK signaling to inhibit proliferation and induce apoptosis in TNBC.
Journal: Cell death discovery
Published: January 06, 2022
Correction to: SOX2 inhibits metastasis in gastric cancer.
Journal: Journal of cancer research and clinical oncology
Published: December 22, 2021
JAC1 suppresses proliferation of breast cancer through the JWA/p38/SMURF1/HER2 signaling.
Journal: Cell death discovery
Published: November 01, 2020
Last Updated: 09/26/2026